Cargando…
Molecular subtypes and a prognostic model for hepatocellular carcinoma based on immune- and immunogenic cell death-related lncRNAs
BACKGROUND: Accumulating evidence shows that immunogenic cell death (ICD) enhances immunotherapy effectiveness. In this study, we aimed to develop a prognostic model combining ICD, immunity, and long non-coding RNA biomarkers for predicting hepatocellular carcinoma (HCC) outcomes. METHODS: Immune- a...
Autores principales: | He, Mingang, Gu, Wenchao, Gao, Yang, Liu, Ying, Liu, Jie, Li, Zengjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720162/ https://www.ncbi.nlm.nih.gov/pubmed/36479122 http://dx.doi.org/10.3389/fimmu.2022.1043827 |
Ejemplares similares
-
Prognostic value and immune landscapes of immunogenic cell death-related lncRNAs in hepatocellular carcinoma
por: Chen, Wanying, et al.
Publicado: (2023) -
Investigation of Hippo pathway-related prognostic lncRNAs and molecular subtypes in liver hepatocellular carcinoma
por: Su, Qiongfei, et al.
Publicado: (2023) -
Identification of prognostic immune-related lncRNAs in pancreatic cancer
por: Ma, Yan, et al.
Publicado: (2022) -
Identification of Prognostic Signature of Necroptosis-Related lncRNAs and Molecular Subtypes in Glioma
por: Zhang, Guanghao, et al.
Publicado: (2022) -
Molecular pattern of lncRNAs in hepatocellular carcinoma
por: Mai, Haoming, et al.
Publicado: (2019)